FANJ
GHDX

Financial Architects (New Jersey)’s Genomic Health, Inc. GHDX Stock Holding History

Financial Architects (New Jersey)’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-34
Closed -$1K – 1688
2017
Q1 		$1K Buy
+34
New +$1.01K ﹤0.01% 1546

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Financial Architects (New Jersey)'s GHDX Position: Q2 2017 in Review

Financial Architects (New Jersey) sold out of Genomic Health, Inc. (GHDX) in Q2 2017, closing a stake of 34 shares — an estimated $1K sold.

Financial Architects (New Jersey) first reported a position in GHDX in Q1 2017 and held it in 1 quarter. The position peaked at $1K in Q1 2017. 124 funds tracked by Wall St. Rank hold GHDX as of Q2 2017.

  • Financial Architects (New Jersey) reported no remaining Genomic Health, Inc. position as of Q2 2017 after selling out during the quarter.
  • Financial Architects (New Jersey) sold 34 Genomic Health, Inc. shares in Q2 2017, an estimated $1K.
  • Financial Architects (New Jersey) first reported a position in Genomic Health, Inc. in Q1 2017 and held it in 1 quarter.
  • Financial Architects (New Jersey)'s Genomic Health, Inc. position peaked at $1K in Q1 2017.
  • 124 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q2 2017.

Based on Financial Architects (New Jersey)'s 13F filing for Q2 2017, filed 21 Jul 2017.